EGFR and non-small cell lung carcinoma: EGFR kinase domain mutations mainly occur at exon 18–21, and increase the kinase activity of EGFR, leading to the hyperactivation of downstream pro-survival signal pathways which promote tumorigenesis of NSCLC cells [8].